CLAIM #11896 · Bristol-Myers Squibb Company (BMY) · 2024Q1 earnings call · Apr 25, 2024 · due Apr 25, 2026
“We plan to utilize our cash flow to repay approximately $10 billion of debt over the next 2 years.”
David Elkins · CFO
PENDING
graded after results covering Apr 25, 2026 are reported
Verify independently
SEC filings for BMY ↗ · Claim quote is verbatim from the 2024Q1 earnings call.